Kythera Biopharmaceuticals Inc Revenue Growth Rates (KYTH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Kythera Biopharmaceuticals Inc  (KYTH)
 

KYTH's Revenue Growth by Quarter and Year

Kythera Biopharmaceuticals Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KYTH Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.29
1st Quarter March 0.00
FY 0.29





KYTH Revenue second quarter 2015 Y/Y Growth Comment
Kythera Biopharmaceuticals Inc in the second quarter 2015 achieved Revenue of $ 0.29 millions compare to recorded in same quarter a year ago.

According to the results reported in the second quarter 2015, Kythera Biopharmaceuticals Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Kythera Biopharmaceuticals Inc' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2015.


KYTH Revenue ( Y/Y Growth %) 2015
 2014 2013 2012
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Kythera Biopharmaceuticals Inc's second quarter 2015 Revenue $ 0.29 millions KYTH's Income Statement
Kythera Biopharmaceuticals Inc's second quarter 2014 Revenue $ 0.00 millions Quarterly KYTH's Income Statement


KYTH Revenue (Quarter on Quarter Growth %)

 2015
 2014 2013 2012
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to KYTH Growth rate Comparisons >> Back to KYTH Growth rate Comparisons >>


Revenue second quarter 2015 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2015 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Kythera Biopharmaceuticals Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYTH's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYTH's II. Quarter Q/Q Revenue Comment


Kythera Biopharmaceuticals Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2015)		 12 Months Ending
(Mar 31 2015)		 12 Months Ending
(Dec 31 2014)		 12 Months Ending
(Sep 30 2014)		 12 Months Ending
(Jun 30 2014)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Jun 30 2015 period, Kythera Biopharmaceuticals Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Kythera Biopharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2015 period, Kythera Biopharmaceuticals Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Kythera Biopharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
KYTH's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Jun 30 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2015
Orthofix Medical Inc -0.03%$ -0.031 millions
Intercept Pharmaceuticals inc -0.09%$ -0.091 millions
Accuray Incorporated-0.25%$ -0.245 millions
Charles River Laboratories International inc -0.47%$ -0.471 millions
Rockwell Medical inc -0.60%$ -0.597 millions
Fonar Corporation-0.86%$ -0.863 millions
Encision Inc -0.89%$ -0.886 millions
Utah Medical Products Inc-0.90%$ -0.896 millions
Hanger inc.-1.09%$ -1.094 millions
Veru Inc -1.10%$ -1.099 millions
Portola Pharmaceuticals inc -1.24%$ -1.242 millions
Alpha Pro Tech Ltd -1.28%$ -1.281 millions
Zimmer Biomet Holdings Inc -1.29%$ -1.293 millions
Alkermes Plc -1.34%$ -1.339 millions
Teva Pharmaceutical Industries Limited-1.57%$ -1.566 millions
Traws Pharma inc -1.60%$ -1.600 millions
Boston Scientific Corporation-1.60%$ -1.602 millions
Pacific Health Care Organization Inc-1.61%$ -1.615 millions
Catalent Inc -1.83%$ -1.828 millions
Lifeloc Technologies Inc -2.32%$ -2.324 millions
Retractable Technologies Inc-2.34%$ -2.340 millions
American Bio Medica Corporation-2.37%$ -2.374 millions
West Pharmaceutical Services Inc -2.49%$ -2.494 millions
Lantheus Holdings Inc -3.04%$ -3.040 millions
Durect Corp-3.06%$ -3.056 millions
Teleflex Incorporated-3.43%$ -3.431 millions
Thermogenesis Holdings Inc -3.52%$ -3.518 millions
Cyteir Therapeutics Inc -3.59%$ -3.586 millions
Conmed Corporation-3.79%$ -3.786 millions
Spectrum Pharmaceuticals Inc -4.00%$ -3.997 millions


About Kythera Biopharmaceuticals Inc Revenue Growth Rates (KYTH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.